CBIC Clarifies GST Rules on Pre-Packaged Goods and Gene Therapy

In a significant update, the Central Board of Indirect Taxes and Customs (CBIC) issued Notification No. 02/2025-Central Tax (Rate) on January 16, 2025, amending the Central Goods and Services Tax Act, 2017 (CGST Act). The changes aim to align the GST framework with evolving industry needs and regulatory standards, introducing updates to the Goods Rate Notification (No. 2/2017-Central Tax Rate).

Key Changes Introduced

1. Inclusion of Gene Therapy:

   • A new entry, "Gene Therapy" (HSN 30), has been added to the GST rate schedule as S. No. 105A.
   • This inclusion is expected to support advancements in biotechnology and healthcare by clarifying the GST rate applicable to gene therapy products.

2. Updated Definition of Pre-Packaged and Labelled Goods:

   • The explanation for ‘pre-packaged and labelled’ goods has been revised to align with the Legal Metrology Act, 2009.
   • The term now applies to commodities meant for retail sale, with a maximum weight or volume of 25 kg or 25 litres per package.
   • Such packages must bear legally mandated declarations under the Legal Metrology Act, 2009, and associated rules.

Broader Applicability

Similar changes have been made under:

• Integrated Goods and Services Tax Act, 2017 (IGST Act)
• Union Territory Goods and Services Tax Act, 2017 (UTGST Act)

These amendments ensure uniformity across central, state, and union territory tax systems, providing clarity to businesses engaged in inter- and intra-state trade.

Immediate Implementation

The notification declares these amendments effective immediately upon publication. Businesses handling gene therapy products and pre-packaged commodities are advised to assess their compliance with the revised definitions and tax implications.

Implications for Key Sectors

1. Healthcare and Biotech:

   • The addition of gene therapy to the GST schedule clarifies its tax treatment, promoting affordability and innovation in advanced medical treatments.

2. Retail and FMCG:

   • The revised definition of pre-packaged and labelled goods ensures tighter compliance with packaging standards, impacting retailers and manufacturers in the FMCG sector.

Conclusion

The notification reflects the government’s intent to enhance transparency and accommodate emerging sectors like biotechnology under the GST framework. Businesses must review their operations to comply with the updated provisions and leverage the benefits offered by these changes.

Official copy of the notification has been attached